Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan

International Journal of Antimicrobial Agents

Volumn 40, Issue 4, 2012, Pages 349-353

  Lai, Chih Cheng ^a   Chu, Chen Chen ^b   Wang, Cheng Yi ^c   Tsai, Hsih Yeh ^b,d   Cheng, Aristine ^b,d   Lee, Yi Chieh ^b   Huang, Yu Tsung ^b,d   Liao, Chun Hsing ^d   Hsueh, Po Ren ^b  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CARDINAL TIEN HOSPITAL   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Antifungal agents; Candida spp.; Candidaemia; Consumption; Correlation

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; PYRROLE DERIVATIVE; VORICONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDEMIA; COMMUNICABLE DISEASE; COMMUNITY ACQUIRED CANDIDEMIA; DRUG USE; HEALTHCARE ASSOCIATED CANDIDEMIA; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INCIDENCE; PICHIA GUILLIERMONDII; PRIORITY JOURNAL; SPECIES DISTRIBUTION; TAIWAN;

ACADEMIC MEDICAL CENTERS; ANTIFUNGAL AGENTS; AZOLES; CANDIDA; CANDIDEMIA; COMMUNITY-ACQUIRED INFECTIONS; DRUG UTILIZATION; ECHINOCANDINS; HUMANS; INCIDENCE; TAIWAN;

EID: 84866045339     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2012.05.024     Document Type: Article

References (27)

1. B. Almirante, D. Rodríguez, B.J. Park, M. Cuenca-Estrella, A.M. Planes, and M. Almela Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 J Clin Microbiol 43 2005 1829 1835
2. L.R. Asmundsdóttir, H. Erlendsdóttir, and M. Gottfredsson Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland J Clin Microbiol 40 2002 3489 3492
3. S.Y. Ruan, and P.R. Hsueh Invasive candidiasis: an overview from Taiwan J Formos Med Assoc 108 2009 443 451
4. H. Wisplinghoff, T. Bischoff, S.M. Tallent, H. Seifert, R.P. Wenzel, and M.B. Edmond Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study Clin Infect Dis 39 2004 309 317
5. P.R. Hsueh, L.J. Teng, P.C. Yang, S.W. Ho, and K.T. Luh Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole Microb Drug Resist 8 2002 311 319
6. M.B. Edmond, S.E. Wallace, D.K. McClish, M.A. Pfaller, R.N. Jones, and R.P. Wenzel Nosocomial bloodstream infections in United States hospitals: a three-year analysis Clin Infect Dis 29 1999 239 244
7. M.A. Pfaller, R.N. Jones, S.A. Messer, M.B. Edmond, and R.P. Wenzel National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group Diagn Microbiol Infect Dis 30 1998 121 129
8. E. Bouza, J. Pérez-Molina, P. Muñoz Cooperative Group of the European Study Group on Nosocomial Infections (ESGNI) Bloodstream infections in Europe. Report of ESGNI-001 and ESGNI-002 studies Clin Microbiol Infect 5 Suppl. 2 1995 2S1-12
9. O. Lyytikäinen, J. Lumio, H. Sarkkinen, E. Kolho, A. Kostiala, and P. Ruutu Nosocomial bloodstream infections in Finnish hospital during 1999-2000 Clin Infect Dis 35 2002 e14 e19
10. A. Voss, J.A. Kluytmans, J.G. Koeleman, L. Spanjaard, C.M. Vandenbroucke-Grauls, and H.A. Verbrugh Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals Eur J Clin Microbiol Infect Dis 15 1996 909 912
11. D. Abi-Said, E. Anaissie, O. Uzun, I. Raad, H. Pinzcowski, and S. Vartivarian The epidemiology of hematogenous candidiasis caused by different Candida species Clin Infect Dis 24 1997 1122 1128
12. M.C. Arendrup, K. Fuursted, B. Gahrn-Hansen, I.M. Jensen, J.D. Knudsen, and B. Lundgren Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility J Clin Microbiol 49 2005 4434 4440
13. A. Borst, M.T. Raimer, D.W. Warnock, C.J. Morrison, and B.A. Arthington-Skaggs Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole Antimicrob Agents Chemother 49 2005 783 787
14. S.S. Magill, C. Shields, C.L. Sears, M. Choti, and W.G. Merz Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy J Clin Microbiol 44 2006 529 535
15. V. Moudgal, T. Little, D. Boikov, and J.A. Vazquez Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis Antimicrob Agents Chemother 49 2005 767 769
16. E. Girão, A.S. Levin, M. Basso, S. Gobara, L.B. Gomes, and E.A. Medeiros Seven-year trend analysis of nosocomial candidaemia and antifungal (fluconazole and caspofungin) use in intensive care units at a Brazilian university hospital Med Mycol 46 2008 581 588
17. E. Poikonen, O. Lyytikäinen, V.J. Anttila, I. Koivula, J. Lumio, and P. Kotilainen Secular trend in candidaemia and the use of fluconazole in Finland, 2004-2007 BMC Infect Dis 10 2010 312
18. T.C. Horan, M. Andrus, and M.A. Dudec CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting Am J Infect Control 36 2008 309 332 Erratum in: Am J Infect Control 2008;36:655
19. M. Ortega, F. Marco, A. Soriano, M. Almela, J.A. Martínez, and J. López Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008 J Hosp Infect 77 2011 157 161
20. H. Richet, P. Roux, C. Des Champs, Y. Esnault, A. Andremont French Candidemia Study Group Candidemia in French hospitals: incidence rates and characteristics Clin Microbiol Infect 8 2002 405 412
21. R. Cisterna, G. Ezpeleta, O. Telleria Spanish Candidemia Surveillance Group Nationwide sentinel surveillance of bloodstream Candida infection in 40 tertiary care hospitals in Spain J Clin Microbiol 48 2010 4200 4206
22. I. Das, P. Nightingale, M. Patel, and P. Jumaa Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK Int J Infect Dis 15 2011 e759 e763
23. A.L. Motta, G.M. Almeida, J.N. Almeida Júnior, M.N. Burattini, and F. Rossi Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complex Braz J Infect Dis 14 2010 441 448
24. Y.C. Chen, S.C. Chang, K.T. Luh, and W.C. Hsieh Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years J Antimicrob Chemother 52 2003 71 77
25. M.F. Cheng, K.W. Yu, R.B. Tang, Y.H. Fan, Y.L. Yang, and K.S. Hsieh Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999 Diagn Microbiol Infect Dis 48 2004 33 37
26. J.J. Lu, S.Y. Lee, and T.S. Chiueh In vitro antifungal susceptibility testing of Candida blood isolates and evaluation of the E-test method J Microbiol Immunol Infect 37 2004 335 342
27. Y.L. Yang, A.H. Wang, C.W. Wang, W.T. Cheng, S.Y. Li, and H.J. Lo Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006 Diagn Microbiol Infect Dis 61 2008 175 180